pubmed-article:20424611 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:20424611 | lifeskim:mentions | umls-concept:C1708063 | lld:lifeskim |
pubmed-article:20424611 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:20424611 | pubmed:dateCreated | 2010-5-12 | lld:pubmed |
pubmed-article:20424611 | pubmed:abstractText | The efficacy and safety of capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer (mCRC) considered unsuitable for receiving first-line chemotherapy with an irinotecan or oxaliplatin-based combination were assessed in a phase II, open, multicentre, uncontrolled study. | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:language | eng | lld:pubmed |
pubmed-article:20424611 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20424611 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20424611 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20424611 | pubmed:month | May | lld:pubmed |
pubmed-article:20424611 | pubmed:issn | 1532-1827 | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:LlombartAA | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:LópezRR | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:BoschCC | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:GilMM | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:EscuderoPP | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:MadroñalCC | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:FeliuJJ | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:SaltzHH | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:González-Baró... | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:García-GirónC... | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:LoseBB | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:BolañosMM | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:SafontM JMJ | lld:pubmed |
pubmed-article:20424611 | pubmed:author | pubmed-author:Castro-Carpeñ... | lld:pubmed |
pubmed-article:20424611 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20424611 | pubmed:day | 11 | lld:pubmed |
pubmed-article:20424611 | pubmed:volume | 102 | lld:pubmed |
pubmed-article:20424611 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20424611 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20424611 | pubmed:pagination | 1468-73 | lld:pubmed |
pubmed-article:20424611 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:meshHeading | pubmed-meshheading:20424611... | lld:pubmed |
pubmed-article:20424611 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20424611 | pubmed:articleTitle | Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer. | lld:pubmed |
pubmed-article:20424611 | pubmed:affiliation | Medical Oncology Department, Hospital La Paz/Autónoma University School of Medicine. IdiPAZ. RETIC, P degrees de la Castellana, Madrid 261- 28046, Spain. jfeliu.hulp@salud.madrid.org | lld:pubmed |
pubmed-article:20424611 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20424611 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:20424611 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:20424611 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20424611 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20424611 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20424611 | lld:pubmed |